Table 3

Pediatric studies evaluating the prevalence of diabetes using administrative data

AuthorCountryData source/yearsCode(s)Age (years)Algorithm (years of data evaluated)Validation source
Guttmann 2010 (11)Canada (Ontario)Institute for Clinical Evaluative SciencesICD-9CM: 250.X<191+ hospital or 2+ outpatient visits (2 years) vs.Hospital charts
1994–2005ICD-10: 10–141–5 outpatient visits ± hospital claim (1 or 2 years)
Dabelea 2009 (18)United States (Navajo Youth)Indian Health Service Facilities 2001–2005ICD-9CM 250.0–250.9<201+ outpatient visit or hospitalization (3 years)Medical records
Hsia 2009 (6)United KingdomPrescription records 1998–2005ATC code A100–181+ prescription claim“General practice research database”
Cox 2008 (7)United States (Missouri)Prescription claims: Scripts Inc.Antidiabetic drug5–191+ prescription claimNone
2002–2005
Kemper 2006 (17)United StatesMarketScan: commercial claims and encounter database (Inpatient, outpatient + drug data)T1DM: 250.X1/X3≤18T1DM: 1+ inpatient or outpatient code ± insulinDrug claim data
1998–2002T2DM: 250.X0/X2T2DM: 1+ inpatient or outpatient code ± no insulin
Acton 2002 (9)United StatesIndian Health Service FacilitiesICD-9CM 250.0–250.9<351+ outpatient codeNone
1990–1998
Blanchard 1997 (10)Canada (Manitoba)Outpatient visits 1985–1993ICD-9CM 2500–145 outpatient visits or 3–4 if <2 years coverageDiabetes Education Registry
  • T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.